ADHD diagnoses surge amid escalating medicine supply challenges
The Sunday Times
The supply issues for ADHD medicines have intensified alongside a significant increase in patient demand. The situation presents as a growing challenge for community pharmacies that are unable to obtain stock. Additionally, GPs are also having to refer patients back to specialist clinics for dose adjustments, which is leading to delays in patient care.
We shared the following comments with the Sunday Times on this pressing issue.
Community Pharmacy England committee member Jas Heer said:
“This cohort of patients are complex, and they’re very sensitive. This is causing a lot of frustration and a lot of worry for them. We’re trying to alleviate that. I personally have not seen it this bad in terms of shortages and I’ve been in pharmacy for over 30 years. In the last 12 to 18 months, I’ve never seen it this bad. There is something broken with the supply chain.”
Our Director of Pharmacy Funding, Mike Dent, also said:
“The problems in primary and secondary care followed years of turbulence across many global supply chains due to Brexit, the Covid pandemic, war in Ukraine, and wider economic instability.”